SOX3 and breast cancer: In contrast, a recent study in breast cancer, utilizing the MDA-MB-231 cell line from invasive ductal carcinoma of the triple negative (TN) molecular subtype and characterized by undifferentiated epithelial cells with mesenchymal morphology, revealed no SOX3 expression.